CHMP Issues Positive Opinion For JASCAYD® (Nerandomilast), Bringing A New IPF And PPF Therapy Closer To Patients In The EU

(MENAFN - GlobeNewsWire - Nasdaq) Not intended for US and UK media Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are life-threatening, progressive lung conditions ...